Un entretien avec Régine Rouzier, présidente de la CRO Cap Research Quel élément central conditionne la réussite d’une étude de phase I ? La réussite d’une étude de phase I passe par la rapidité dans l’exécution et par la qualité du travail rendu. Ce sont les deux piliers fondamentaux d’un…..
An interview with Régine Rouzier, president of the CRO Cap Research What is the central issue to successfully perform a phase I trial? The success of a phase I study depends on the speed in execution and the excellence and quality of returned work. These are the two fundamental pillars…..
BioPharmAnalyses is happy to announce the release of the first issue of its "BRIEFING ON CART-T CELLS TRIALS" CAR-T cells therapies are at the forefront of innovation in oncology "BRIEFING ON CART-T CELLS TRIALS" provides you with an accurate overview to explore the latest trials in this hot and rapidly evolging…..
3D cell and tissue cultures are an emerging field of biomedical research, enabling scientists to study the physiology of human organs and tissues in ways that have not been possible before. However, while these 3D cultures can be generated, technology that accurately assesses their functionality in real time has not…..
The genome editing system CRISPR has become a hugely important tool in medical research. The targeting system can travel to different points on the genome, guided by a short sequence of RNA, where the DNA-cutting enzyme Cas9 then makes the desired edits. However, CRISPR-Cas9 remains limited in the number of…..
The 2018 Nobel Prize in Physiology or Medicine has been jointly awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. During the 1990s, in his laboratory at the University of California, Berkeley, James P. Allison studied the T-cell protein CTLA-4.…..
The international summer school « Microfluidics for health : from sciences to business » will take place from 27th to 31st August 2018 in Pierre-Gilles de Gennes Institute (IPGG), in Paris. 30 places are available upon selection. Applications are open until 19th July. Go to www.microfluidicsforhealth.paris. You can also contact …..